{"denoms":[{"counts":[{"groupId":"BG000","value":"86"}],"units":"Participants"}],"groups":[{"description":"Temozolomide capsules 150 mg/m\\^2 daily on a 7-day on/7-day off schedule for each 28-day cycle. Temozolomide is the only treatment group, and and all participants received the same dosing regimen.","id":"BG000","title":"Temozolomide"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"10.4","value":"62.9"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"29"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"57"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"}]}